Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase 3 28Phase 1 17Phase 2/3 8Phase 1/2 5Phase NA 1Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Standard of Care 177Blood Specimen Collection 138Exercise 123Educational Status 114Methods 109Interviews as Topic 106Practice Guidelines as Topic 105Surveys and Questionnaires 104Early Intervention, Educational 93Magnetic Resonance Spectroscopy 80Specimen Handling 78Radiosurgery 68Radiotherapy 56Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 34Resistance Training 32Drug Therapy 32Therapeutics 31Surgical Procedures, Operative 31Diet Therapy 30Counseling 29Behavior Therapy 29Acupuncture Therapy 25Proton Therapy 24Nutrition Assessment 24Exercise Test 24Magnetic Resonance Imaging 23Radiation 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × 1,2-diaminocyclohexaneplatinum II citrate × 1 year × Clear all
NCT02194738 2026-05-29

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

National Cancer Institute (NCI)

Phase NA Active not recruiting
8,300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡